Skip to main content

Table 1 Patients characteristics

From: Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

Clinical characteristics

Number (n)

%

Total number

71

100

Age (years)

  

  Median

59

 

  Range

29 - 75

 

Gender

  

  Male

48

68

  Female

23

32

Disease stage

  

  IIIA

66

93

  IIIB

5

7

Tumor classification

  

  T1

7

10

  T2

43

60

  T3

16

23

  T4

5

7

Lymph node status

  

  N2

71

100

Tumor location

  

  Right upper lobe

28

39

  Right middle lobe/central

5

7

  Right lower lobe

9

13

  Left upper lobe

16

23

  Left lower lobe

13

18

Tumor histology

  

  Squamous cell

25

35

  Adenocarcinoma

41

58

  Large cell

3

4

  Other

2

3

Surgery type

  

  Lobectomy

44

62

  Bi-lobectomy

7

10

  Pneumonectomy

20

28

Resection status

  

  R0

53

75

  R1

18

25

Resected lymph nodes

  

  Median

33

 

  Range

10 – 60

 

Chemotherapy

  

  Induction

23

32

  Adjuvant

48

68

RT dose (Gy)

  

  Median

50

 

  Range

40 - 60